Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Suppression”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Not applicableStudy completedNCT03590938
What this trial is testing

Lynparza Breast Cancer Clinical Experience Investigation

Who this might be right for
Breast Cancer
AstraZeneca 111
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06992739
What this trial is testing

Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)EGFRMyelosuppression
The First Affiliated Hospital of Xiamen University 49
Not applicableStudy completedNCT05442177
What this trial is testing

Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity

Who this might be right for
Myelosuppression
Taichung Tzu Chi Hospital 35
Not applicableApproved For MarketingNCT04504513
What this trial is testing

Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer

Who this might be right for
Myelosuppression AdultChemotherapeutic ToxicitySmall Cell Lung Cancer
G1 Therapeutics, Inc.
Not applicableUnknownNCT06140082
What this trial is testing

Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression

Who this might be right for
Non-small Cell Lung Cancer
LI YAN 477
Large-scale testing (Phase 3)UnknownNCT03740464
What this trial is testing

Long-acting G-CSF for Febrile Neutropenia

Who this might be right for
Epithelial Ovarian CancerColony Stimulating FactorsFebrile Neutropenia+3 more
Lei Li 556
Not applicableUnknownNCT04905329
What this trial is testing

Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations

Who this might be right for
Solid TumorHigh-Risk CancerBreast Cancer+3 more
Moscow Clinical Scientific Center 285
Testing effectiveness (Phase 2)Looking for participantsNCT07205536
What this trial is testing

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Who this might be right for
MyelosuppressionThoracic NeoplasmsChemoradiotherapy
Affiliated Hospital of Nantong University 30
Not applicableUnknownNCT01193933
What this trial is testing

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment

Who this might be right for
Ph-negative Adult Acute Lymphoblastic Leukemia
National Research Center for Hematology, Russia 321
Testing effectiveness (Phase 2)Ended earlyNCT04887831
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab

Who this might be right for
Urothelial CarcinomaBladder CancerMyelosuppression Adult+2 more
G1 Therapeutics, Inc. 92
Post-approval studies (Phase 4)Study completedNCT00969462
What this trial is testing

Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Meir Medical Center 18
Early research (Phase 1)Ended earlyNCT03974516
What this trial is testing

Careseng 1370 for Healthy Volunteers

Who this might be right for
Chemotherapy-induced Myelosuppression
i Cure Biotech Co., Ltd. 13
Post-approval studies (Phase 4)Looking for participantsNCT05874401
What this trial is testing

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Pharmacosmos A/S 302
Early research (Phase 1)Ended earlyNCT04022876
What this trial is testing

ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Who this might be right for
Non Small Cell Lung CancerSmall-cell Lung Cancer
Aileron Therapeutics, Inc. 35
Not applicableLooking for participantsNCT06611072
What this trial is testing

OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study

Who this might be right for
Ovarian NeoplasmsOvarian CancerOvarian Carcinoma+2 more
Gynaecologisch Oncologisch Centrum Zuid 90
Large-scale testing (Phase 3)Ended earlyNCT00518869
What this trial is testing

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Who this might be right for
Quality of LifeFatigueComplementary
PhytoHealth Corporation 13
Not applicableStudy completedNCT03247010
What this trial is testing

Bone Marrow Suppression and Recovery During Radionuclide Treatment

Who this might be right for
Castration-resistant Prostate Cancer
Rigshospitalet, Denmark 68
Testing effectiveness (Phase 2)UnknownNCT01762514
What this trial is testing

A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

Who this might be right for
Nasopharyngeal NeoplasmsSalivary Gland DiseasesBone Marrow Diseases+1 more
Sun Yat-sen University 360
Not applicableUnknownNCT02829216
What this trial is testing

Graft-versus-host Disease Associated Myelosuppression

Who this might be right for
Abnormal HematopoiesisAllogenic DiseaseGraft vs Host Disease
Technische Universität Dresden 50
Load More Results